Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Condition(s):Charcot-Marie-Tooth Disease, Type IALast Updated:February 20, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Charcot-Marie-Tooth Disease, Type IALast Updated:February 20, 2024Active, not recruiting
Condition(s):Alcohol DependenceLast Updated:February 13, 2020Terminated
Condition(s):Bioavailability, Therapeutical Indication Not StudiedLast Updated:October 21, 2009Completed
Condition(s):Cerebral PalsyLast Updated:November 19, 2010Completed
Condition(s):Spasticity, Muscle; Spinal Cord InjuriesLast Updated:March 4, 2024Not yet recruiting
Condition(s):Stiff-Person SyndromeLast Updated:May 14, 2019Unknown status
Condition(s):Lumbar Disc HerniationLast Updated:August 25, 2021Completed
Condition(s):Cerebral Palsy, SpasticLast Updated:May 15, 2023Not yet recruiting
Condition(s):Trigeminal NeuralgiaLast Updated:October 15, 2021Unknown status
Condition(s):HealthyLast Updated:February 11, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.